Myocardial Ischemia Without Obstructive Coronary Stenoses

Study Overview
=================
Brief Summary
-----------------
Coronary-related myocardial ischemia can result from obstructive epicardial stenosis or non-obstructive causes including coronary microcirculatory dysfunction and vasomotor disorders. This prospective study has been created in order to provide knowledge in the field of non-obstructive coronary artery disease.

Detailed Description
-----------------
All-comer patients referred for coronary physiological assessment with pressure-flow measurements and acetylcholine endothelial function test, aimed to investigate different aspects of non-obstructive coronary artery disease, will be enrolled. Coronary hemodynamics during adenosine or acetylcholine evaluation will be measured either with a physiology wire equipped with pressure and temperature sensors (Abbott), or with a physiology wire equipped with pressure sensor and Doppler (Philips). Non-endothelium-dependent functional assessment will be performed with intravenous or intracoronary adenosine administration following the standard practice. Endothelium-dependent functional assessment will be performed with intracoronary acetylcholine bolus administration following the standard practice, which includes continuous 12-lead ECG monitorization. Microcirculatory dysfunction and vasomotor disorders will be diagnosed according to the criteria from the last European expert consensus on Ischaemia with Non-Obstructive Coronary Arteries (INOCA). Medical therapy will be adjusted on the basis of physiology study results and patients will be followed at 30 days, 1-, 2- and 5-years either at the outpatient clinic or by telephone contact. The Seattle Questionnaire of Angina will be applied during follow-up for obtaining an objective characterisation of the angina status. OBJECTIVES OF THE STUDY: To investigate the coronary hemodynamics across the spectrum of coronary microcirculatory dysfunction. To investigate the coronary hemodynamics across the spectrum of vasomotor disorders. To investigate the impact of coronary microcirculatory dysfunction on clinical outcomes and patient symptoms at long-term follow-up. To investigate the impact of coronary vasomotor disorders on clinical outcomes and patient symptoms at long-term follow-up. To investigate the impact of a stratified medical therapy (guided by invasive physiology study) on patient symptoms. To investigate the role of microcirculatory dysfunction and vasomotor disorders in different settings of ischemic heart disease (i.e., recurrent angina despite successful percutaneous coronary intervention; myocardial infarction without obstructive coronary artery disease; left ventricular dysfunction (either systolic or diastolic) with or without heart failure). To develop new, alternative methods aimed to assess the coronary microcirculation. To investigate the role of myocardial bridging on myocardial ischemia generating mechanisms. To document safety of intracoronary testing in routine clinical practice.

Official Title
-----------------
Myocardial Ischemia Without Obstructive Coronary Stenoses: A Prospective Observational Study With Invasive Coronary Pressure and Flow Measurements and Endothelial Function Test

Conditions
-----------------
Myocardial Ischemia, Non-Obstructive Coronary Atherosclerosis, Microvascular Coronary Artery Disease, Vasospastic Angina, Myocardial Bridging

Intervention / Treatment
-----------------
* Diagnostic Test: Invasive coronary endothelium-dependent and non-endothelium-dependent physiological assessment


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Written informed consent available. Age ≥ 18 years. Patient eligible for invasive physiological assessment with adenosine and / or acetylcholine. Exclusion Criteria: Hemodynamic instability. Anticipated technical issues for physiology wire measurements. Culprit vessel of acute coronary syndrome Contraindications for adenosine administration. Contraindications for acetylcholine test. Reduced life expectancy (less than 1 year).

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Myocardial ischemia without obstructive coronary stenosis<br> | Diagnostic Test: Invasive coronary endothelium-dependent and non-endothelium-dependent physiological assessment<br>* Coronary hemodynamics and vessel anatomical measures obtained during adenosine and acetylcholine evaluation with a dedicated physiology wire<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Patient-oriented composite outcome | Incidence of a patient-oriented composite outcome, a composite of any death, nonfatal myocardial infarction, any ischemia-driven revascularization or hospitalization due to unstable angina pectoris | Up to 5 years | 
| Vessel-oriented composite outcome | Incidence of a vessel-oriented composite outcome, a composite of cardiac death, target-vessel related myocardial infarction or target-vessel revascularization | Up to 5 years | 
| Patient symptoms burden | Change in the Seattle questionnaire of angina scoring, associated to stratified medical treatment. Minimum is 0 and maximum is 100 and lower scores indicate worse outcome | Up to 12 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Cumulative incidence of any death |  | Up to 5 years | 
| Cumulative incidence of cardiac death |  | Up to 5 years | 
| Cumulative incidence of nonfatal myocardial infarction |  | Up to 5 years | 
| Cumulative incidence of ischemia-driven revascularization |  | Up to 5 years | 
| Safety of invasive comprehensive coronary functional testing with adenosine and acetylcholine | Adverse events / complications linked to invasive functional testing | During procedure | 
| Emergency room visit due to angina episode |  | Up to 5 years |